检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:来亚杰[1] 王银平[1] 吴燕[1] 钟明华[1]
出 处:《中日友好医院学报》2000年第3期140-142,共3页Journal of China-Japan Friendship Hospital
摘 要:目的 :评价血小板聚集 (PA)试验在脑梗塞诊断和防治中的价值。方法 :以二磷酸腺苷 (ADP)、胶原 (Col)及肾上腺素 (Adr)为诱导剂 ,应用多频道血小板聚集仪 ,对 68例急性期或非急性期 (亚急性期或慢性期 )脑梗塞患者及 30例正常对照进行PA检测。结果 :在脑梗塞未用药组 ,急性期患者以ADP和Col为诱导剂 ,PA率均明显低于正常对照组(P <0 0 1 ,P <0 0 5)。而以Adr为诱导剂 ,PA率均明显高于对照组 (P <0 0 5) ;非急性期患者未用药组 ,以ADP、Col及Adr为诱导剂 ,PA率均明显高于对照组 (P <0 0 1 ,P <0 0 5)。在用药组 ,无论急性期或非急性期患者 ,3种诱导剂的PA率均明显低于对照组 (P<0 0 1 )。结论 :以ADP、Col及Adr为诱导剂 ,在脑梗塞不同期进行PA检测 ,对脑梗塞的诊断及指导治疗均有一定的价值。PA检测可作为脑梗塞治疗结果的监测。Objective:To evaluate the role of platelet aggregation(PA) in the diagnosis,prevention and treatment of the patients with cesebral infanction.Methods:We examed PA rate of 68 patients with cerebral infaretion during the acute phase and non-acute phase(subacute or chronic phase) and 30 controls by using a multiple frequency channel PA instrument(PAC-8 S,Japan) induced by adenosine diphosphat(ADP),Collagen(Col) and adrenaline(Adr).Result:In the untherapy group,the PA rate in the acute phase was significantly less than in the controls( P<0 01,P<0 05) induced by ADP and Col but it was higher in the acute phase than in the controls induced by Adr.In the untherapy group of the non-acute phase,the PArate were all significantly higher than in the controls induced by ADP,Col and Adr.In the group with treatment,whether in the acute phase ornon-acute phase,the PA sate were all significanfly less than in thecontrols( P <0 01) induced by ADP,Col and Adr.Conclusion:It may be a valuable method for the diagnosis and treatment of cerebral infarction in different phase of this disease,in which PA rate induced by ADP,Col and Adr were measured.PA test may monitor the effect of therapy in cerebral infarction.
分 类 号:R743.3[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.144.135.25